We've found
13,253
archived clinical trials in
Arthritis
We've found
13,253
archived clinical trials in
Arthritis
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Study of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Updated: 12/22/2016
A Randomized, Double-Blind, Multi-Dose, Placebo-Controlled Study to Evaluate the Efficacy and Safety of REGN475 in Patients With Pain Due to Osteoarthritis of the Knee or Hip
Status: Enrolling
Updated: 12/22/2016
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Click here to add this to my saved trials
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Post PMA-Approval Study: New Enrollment Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Updated: 1/5/2017
Cormet Resurfacing Hip System Post PMA-Approval Study Post-approval Study Group (New Enrollment)
Status: Enrolling
Updated: 1/5/2017
Click here to add this to my saved trials
Duration of Immune Response to Influenza Vaccination in Patients With RA
Updated: 1/5/2017
Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents
Status: Enrolling
Updated: 1/5/2017
Duration of Immune Response to Influenza Vaccination in Patients With RA
Updated: 1/5/2017
Duration of Immune Response to Influenza Vaccination in Patients With Rheumatoid Arthritis Receiving Treatment With Biologic Agents
Status: Enrolling
Updated: 1/5/2017
Click here to add this to my saved trials
Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Arthroplasty
Updated: 1/11/2017
The Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Replacements Performed Within One Week
Status: Enrolling
Updated: 1/11/2017
Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Arthroplasty
Updated: 1/11/2017
The Effect of Preop Nutritional Status on Outcomes of Staged Bilateral Total Knee Replacements Performed Within One Week
Status: Enrolling
Updated: 1/11/2017
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
A Phase II Study Evaluating the Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis
Updated: 1/23/2017
Efficacy and Safety of AbGn-168H in Patients With Active Psoriatic Arthritis: a 24-week, Open-label, Multi-center, Phase II Proof of Principle Trial.
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective
Updated: 1/23/2017
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve LDA or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective When Treating to Target
Status: Enrolling
Updated: 1/23/2017
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve Low Disease Activity (LDA) or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective
Updated: 1/23/2017
An Evaluation of the Optimal Dose of Tofacitinib Needed to Achieve LDA or Clinical Remission in Patients With Active Rheumatoid Arthritis (RA) as Measured From a Clinical and Structural Perspective When Treating to Target
Status: Enrolling
Updated: 1/23/2017
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
A Study of the Safety and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Updated: 1/30/2017
A Single-Blind, Multiple Ascending-Dose Pilot Study of the Safety, Tolerability, Pharmacokinetics, and Effectiveness of Orally Administered CR845 in Patients With Osteoarthritis of the Hip or Knee
Status: Enrolling
Updated: 1/30/2017
Click here to add this to my saved trials
The Health Log: A Randomized Clinical Trial
Updated: 1/31/2017
The Use of a Health Management Tool in a Clinic Setting to Improve Self-Efficacy in Rheumatoid Arthritis Patients: a Randomized Clinical Trial.
Status: Enrolling
Updated: 1/31/2017
The Health Log: A Randomized Clinical Trial
Updated: 1/31/2017
The Use of a Health Management Tool in a Clinic Setting to Improve Self-Efficacy in Rheumatoid Arthritis Patients: a Randomized Clinical Trial.
Status: Enrolling
Updated: 1/31/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Updated: 2/22/2017
A Multicenter, Randomized, Double-Blind, Study Comparing the Efficacy and Safety of Continuing Versus Withdrawing Adalimumab Therapy in Maintaining Remission in Subjects With Non-Radiographic Axial Spondyloarthritis
Status: Enrolling
Updated: 2/22/2017
Click here to add this to my saved trials